ReviewTouchREVIEWS in endocrinology2026

Burosumab for X-linked Hypophosphataemia and Tumour-induced Osteomalacia in Adults.

Simon Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.